New molecular targets in bone metastases

Antonio Russo, Francesco Pantano, Lucia Lombardi, Alice Zoccoli, Gucciardino, Fratto, Sara Galluzzo, Evaristo Maiello, Bruno Vincenzi, Nicola Silvestris, Colucci, Giuseppe Tonini, Elisabetta Riva, Daniele Santini, Daniele Santini, Sergio Rizzo

Risultato della ricerca: Articlepeer review

42 Citazioni (Scopus)


Bone metastases have a major impact on morbidity and on mortality in cancer patients. Despite its clinical relevance, metastasis remains the most poorly elucidated aspect of carcinogenesis. The biological mechanisms leading to bone metastasis establishment have been referred as " vicious circle," a complex network between cancer cells and the bone microenvironment. This review is aimed to underline the new molecular targets in bone metastases management other than bisphosphonates. Different pathways or molecules such as RANK/RANKL/OPG, cathepsin K, endothelin-1, Wnt/DKK1, Src have recently emerged as potential targets and nowadays preclinical and clinical trials are underway. The results from those in the advanced clinical phases are encouraging and underlined the need to design large randomised clinical trials to validate these results in the next future.Targeting the bone by preventing skeletal related events (SREs) and bone metastases has major clinical impact in improving survival in bone metastatic patients and in preventing disease relapse in adjuvant setting. © 2010 Elsevier Ltd.
Lingua originaleEnglish
pagine (da-a)S6-S10
Numero di pagine5
RivistaCancer Treatment Reviews
Stato di pubblicazionePublished - 2010

All Science Journal Classification (ASJC) codes

  • Oncology
  • Radiology Nuclear Medicine and imaging

Fingerprint Entra nei temi di ricerca di 'New molecular targets in bone metastases'. Insieme formano una fingerprint unica.

Cita questo